Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China

Overview of attention for article published in Frontiers in oncology, April 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Comparative efficacy of six programmed cell death Protein-1 inhibitors as first-line treatment for advanced non-small cell lung cancer: a multicenter retrospective cohort study

Article in Frontiers in Pharmacology (May 2024)

Ionic Liquids Nanoliposomes Based on Targeted and Active Permeability for Enhanced Combination Chemotherapy Efficiency

Article in Nano (December 2023)

Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer: a multicentre retrospective study

Article in Discover Oncology (June 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.